Ignite Creation Date:
2024-05-06 @ 6:51 PM
Last Modification Date:
2024-10-26 @ 2:55 PM
Study NCT ID:
NCT05803122
Status:
COMPLETED
Last Update Posted:
2023-04-07
First Post:
2023-03-26
Brief Title:
Validation of the I-UDS Neuropsychological Battery
Sponsor:
IRCCS National Neurological Institute C Mondino Foundation
Organization:
IRCCS National Neurological Institute C Mondino Foundation
Study Overview
Official Title:
Validation of the I-UDS Neuropsychological Battery in Patients With Mild Cognitive Impairment and Alzheimers Disease
Status:
COMPLETED
Status Verified Date:
2023-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The current project entails the validation of the Italian version of the Uniform Data Set I-UDS neuropsychological in patients with neurodegenerative diseases specifically in patients with Mild Cognitive Impairment MCI and Alzheimers Disease AD Specifically the final aim is to explore the ability of the battery to differentiate the cognitive profiles of the two groups of patients
Detailed Description:
The harmonization of procedures for neuropsychological assessment in dementia disorders is essential for the development of shared activities and projects within the IRCCS Network of Neuroscience and Neurorehabilitation RIN To this end a previous project of the network was dedicated to the translation and adaptation of the Uniform Data Set UDS neuropsychological battery following the similar initiative of the National Alzheimers Coordinating Center NACC USA This project led to the creation of the I-UDS which can be administered via a tablet application and consists of tests aimed at investigating different cognitive domains namely memory attention language executive and visuospatial skills Normative data were obtained from a sample of 433 healthy participants In order to be able to use the I-UDS battery in clinical and research settings it is essential to validate its application in patients with neurodegenerative diseases In particular in line with the NACC initiative the battery aims to trace and highlight the continuum between Mild Cognitive Impairment MCI and Alzheimers Disease AD The present multicenter study therefore aims to test the I-UDS battery in patients with clinical diagnoses of MCI and AD in order to explore its ability to differentiate the cognitive profiles of the two groups of patients
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None